People: Achillion Pharmaceuticals Inc (ACHN.OQ)
13 Sep 2019
Mr. Anthony S. Gibney is Executive Vice President, Chief Business Officer of the Company. Prior to joining Achillion, Mr. Gibney was an investment banker for almost 25 years, completing over 150 merger and acquisition and financing transactions as a lead advisor to US and EU-based life science clients. Most recently, he was a Managing Director and Co-Head of the Biotechnology Investment Banking Team at Leerink Partners. Prior to that, Tony worked in the Healthcare Group at Merrill Lynch, Inc., where he ultimately led the East Coast Biotechnology origination effort as a Managing Director. Tony began his professional career as an analyst and associate in the Healthcare Investment Banking Group at Lehman Brothers Inc. Tony holds a Bachelor of Arts degree in History and Economics from Yale University.
|Total Annual Compensation,||--|
|Restricted Stock Award,||--|
|Long-Term Incentive Plans,||--|
|Fiscal Year Total,||--|